Imaging
Collateral Ligament Tear (Knee)
- Preliminary Diagnosis: Medial Collateral Ligament (MCL) Tear (knee)
-
I. What imaging technique is first-line for this diagnosis?
- II. Describe the advantages and disadvantages of this technique for diagnosing MCL tears (knee).
-
III. What are the contraindications for the first-line imaging technique?
-
IV. What alternative imaging techniques are available?
- V. Describe the advantages and disadvantages of the alternative techniques for diagnosing MCL tears.
- VI. What are the contraindications for the alternative imaging techniques?
Preliminary Diagnosis: Medial Collateral Ligament (MCL) Tear (knee)
I. What imaging technique is first-line for this diagnosis?
MRI of the knee. There is no need for contrast.
II. Describe the advantages and disadvantages of this technique for diagnosing MCL tears (knee).
Advantages
Diagnostic for MCL tears.
Useful not only for diagnosis, but for categorization of the MCL tears according to severity (mild sprain, partial tears, complete tears, and detachments), location (proximal/middle/distal, superficial/deep), as well as for depicting chondral/osteochondral injuries, meniscal tears, ACL tears, and hemarthrosis.
Does not include exposure to ionizing radiation.
Disadvantages
Expensive.
Time consuming.
Requires patient cooperation, and the images are susceptible to motion artifact. Uncooperative patients may need sedation.
Closed bore magnets may be uncomfortable for claustrophobic and obese patients.
III. What are the contraindications for the first-line imaging technique?
Patients with non-MRI compatible implanted devices.
MR imaging is also relatively contraindicated in pregnant women during the first trimester, due to a lack of research about the effect of the magnetic field on the embryo.
IV. What alternative imaging techniques are available?
Computed tomography with intra-articular injection of contrast (CT-arthrography).
Plain radiographs.
Ultrasound (gray scale).
V. Describe the advantages and disadvantages of the alternative techniques for diagnosing MCL tears.
CT arthrography
Advantages
Does not involve magnetic fields, and therefore is a suitable method for patients with metallic implants/devices.
The contrast injected into the joint space extravasates into the adjacent medial soft tissues in acute MCL injuries.
This technique might be diagnostic or require additional evaluation.
Disadvantages
Exposure to ionizing radiation.
Is considered an invasive procedure, including intra-articular injection of contrast media, with possible complications including chemical synovitis, infection, hemorrhage, and pain.
Subacute or superficial MCL tears may not be depicted by this imaging method.
Plain radiographs
Advantages
Readily available, fast, low-cost imaging technique.
Chronic injuries may present with calcification or ossification of the MCL (Pellegrini-Stieda syndrome).
Disadvantages
Routine radiographic abnormalities associated with acute MCL tears are not diagnostic.
Exposure to ionizing radiation.
Plain film imaging is limited for soft tissue evaluation, offering poor anatomic detail.
Ultrasound
Advantages
Ultrasound may be diagnostic in high grade MCL tears.
Safe, cost-effective, quick, readily available method.
Disadvantages
Ultrasound imaging is less accurate for low grade/partial tears.
Operator-dependent imaging technique.
VI. What are the contraindications for the alternative imaging techniques?
CT arthrography and radiographs
Contraindicated in pregnant women, especially during the first and second trimesters.
In patients with prior allergic reactions (e.g., itching, rash, angioedema of the throat, anaphylaxis) to iodinated intravenous contrast, one should consider the risks and benefits of CT arthrography. These patients should be pretreated with steroids and antihistamines for a minimum of 13 hours prior to imaging.
Plain radiographs
No significant contraindications. Some institutions may require consent for pregnant women.
Ultrasound
There are no contraindications for ultrasound.
Copyright © 2017, 2014 Decision Support in Medicine, LLC. All rights reserved.
No sponsor or advertiser has participated in, approved or paid for the content provided by Decision Support in Medicine LLC. The Licensed Content is the property of and copyrighted by DSM.
Sign Up for Free e-newsletters
ONA Articles
- FDA: Number of U.S. Women With Breast Implant-Caused Cancer Has Increased
- Takeda to Collaborate With MSKCC on CAR-T Therapies for Multiple Myeloma
- Sequential Immunotherapy, Targeted Therapy Linked to Cutaneous Adverse Events in Advanced Melanoma
- Immunotherapy for HER2-positive Breast Cancer: Recent Advances and Combination Therapeutic Approaches
- NIH Establishes Educational Program on Genomics, Genetics for Oncology Nurses
- Oncology Nurse Navigation Facilitates Timely Treatment of Pancreatic Cancer
- Helping Patients Face the Challenge of Eating Healthy During Cancer Treatment
- Oncology Nurses Weigh In on Their Patient-Centered Communication Practices, Needs
- Substitute for Lidocaine
- CART cell therapy for prostate cancer: status and promise
- Immunotherapy for HER2-positive Breast Cancer: Recent Advances and Combination Therapeutic Approaches
- Survey Demonstrates Relationship Between Symptom Burden, Medical Disability Leave Among Myeloproliferative Neoplasms
- A Review of Clinical Outcomes in Patients With Early-Stage Burkitt Lymphoma
- FDA: Number of U.S. Women With Breast Implant-Caused Cancer Has Increased
- USPSTF Still Recommends Against Pancreatic Cancer Screening
Regimen and Drug Listings
GET FULL LISTINGS OF TREATMENT Regimens and Drug INFORMATION
Bone Cancer | Regimens | Drugs |
Brain Cancer | Regimens | Drugs |
Breast Cancer | Regimens | Drugs |
Endocrine Cancer | Regimens | Drugs |
Gastrointestinal Cancer | Regimens | Drugs |
Genitourinary Cancer | Regimens | Drugs |
Gynecologic Cancer | Regimens | Drugs |
Head and Neck Cancer | Regimens | Drugs |
Hematologic Cancer | Regimens | Drugs |
Lung Cancer | Regimens | Drugs |
Other Cancers | Regimens | |
Rare Cancers | Regimens | |
Skin Cancer | Regimens | Drugs |